Collaboration will allow Evotec to evaluate small molecules developed by Adapsyn
Chemical bioinformatics company, Adapsyn Bioscience Inc., and Evotec SE have entered into a strategic collaboration…
September 21, 2022 - 3 minutes
News and Trends
NodThera reveals positive results for inflammasome inhibitors
Biotech company NodThera has announced positive phase 1 clinical readouts for its first and second…
September 21, 2022 - 2 minutes
Quinten Health closes financing round to advance disease modeling platforms
A financing round to advance disease modeling platforms and virtual twins in real world has…
September 21, 2022 - 3 minutes
FDA clears Cellenkos ALS drug for trial
Cellenkos, Inc., a clinical stage biotech company, has announced that the U.S. Food and Drug…
September 21, 2022 - 3 minutes
Anina – reshaping the future of food by upcycling rejected vegetables
Two industrial design students were so concerned by the huge amounts of perfectly good fresh…
September 21, 2022 - 5 minutes
Poolbeg to investigate melioidosis vaccine candidate
Poolbeg Pharma has signed an exclusive agreement with University College Dublin (UCD) through NovaUCD, the…
September 21, 2022 - 2 minutes
Hoag’s high hopes for new drug with Alzheimer’s disease trial
Hoag's Pickup Family Neurosciences Institute is initiating a clinical trial for what it says is…
September 21, 2022 - 2 minutes
Novo Nordisk Foundation investing $200M for first quantum computer for life sciences research
The Novo Nordisk Foundation has awarded a grant of $200 million to establish the first…
September 21, 2022 - 5 minutes
New Bio Studio program collaboration looks to create life science start-ups
The BioInnovation Institute (BII), has entered a collaboration with Imperial College London in the U.K.…
September 21, 2022 - 3 minutes
ten23 health completes superstructure of new sterile production facility
ten23 health, a global contract development and manufacturing organization (CDMO) has completed the superstructure of…
September 20, 2022 - 2 minutes
Bioreactor platform launched to support process development for cell and gene therapy
A medical technology company, today announced the launch of a bioreactor platform that supports process…
September 20, 2022 - 3 minutes
CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development
In a deal with a potential value of $110 million over the next five years,…
September 20, 2022 - 3 minutes
